Attovia Therapeutics, Inc. (ATTO) stock
ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$15.53+0.67 (+4.51%)
Close on Nov 18, 2026Market cap $708.96MP/E –Yield –
Attovia Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$25.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.16M | – |
See a number that looks wrong?